Stay updated on Intratumoral SD-101 + Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the Intratumoral SD-101 + Pembrolizumab Clinical Trial page.

Latest updates to the Intratumoral SD-101 + Pembrolizumab Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRevision label on the page updated from v3.6.1 to v3.6.3, reflecting a newer site revision. No study details or content were modified.SummaryDifference0.0%

- Check17 days agoChange Detected- Revision in the page footer updated from v3.6.0 to v3.6.1, signaling a new site release. This is a minor update and does not modify the study content or how users interact with the page.SummaryDifference0.0%

- Check32 days agoChange DetectedThe page now indicates that recruitment has ended and adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) along with an updated Intervention/Treatment label and a site revision tag (v3.6.0); the older Intervention / Treatment label and the revision tag (v3.5.5) were removed.SummaryDifference0.3%

- Check39 days agoChange DetectedThe site release notes updated the version from v3.5.4 to v3.5.5, signaling a small platform update rather than changes to study information.SummaryDifference0.0%

- Check53 days agoChange DetectedRelease notes now display Revision: v3.5.4, replacing the previous Revision: v3.5.3. This indicates the page has been updated to reflect the latest revision.SummaryDifference0.0%

- Check75 days agoChange DetectedThe site shows an updated revision from v3.5.2 to v3.5.3, indicating an incremental platform release. This update does not modify the study details presented on the page.SummaryDifference0.0%

Stay in the know with updates to Intratumoral SD-101 + Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Intratumoral SD-101 + Pembrolizumab Clinical Trial page.